What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Diabetes mellitus
Christoph Wanner mainly investigates Internal medicine, Endocrinology, Kidney disease, Cardiology and Dialysis.
Christoph Wanner combines subjects such as Diabetes mellitus and Surgery with his study of Internal medicine.
Christoph Wanner works mostly in the field of Surgery, limiting it down to topics relating to Myocardial infarction and, in certain cases, Stroke and Statin, as a part of the same area of interest.
In his study, which falls under the umbrella issue of Kidney disease, Nephrology, Disease, Blood pressure, Transplantation and Cohort study is strongly linked to Intensive care medicine.
His Cardiology research includes themes of Left ventricular hypertrophy and Diastole.
The various areas that Christoph Wanner examines in his Dialysis study include Cardiovascular calcification and Uremia.
His most cited work include:
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial (1691 citations)
- Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data (459 citations)
- The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. (394 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Kidney disease, Endocrinology, Diabetes mellitus and Cardiology are his primary areas of study.
As part of his studies on Internal medicine, Christoph Wanner frequently links adjacent subjects like Type 2 diabetes.
Disease is closely connected to Intensive care medicine in his research, which is encompassed under the umbrella topic of Kidney disease.
The study incorporates disciplines such as Left ventricular hypertrophy and Blood pressure in addition to Cardiology.
His Hemodialysis research is multidisciplinary, incorporating elements of Gastroenterology and Hazard ratio.
The concepts of his Renal function study are interwoven with issues in Creatinine, Proteinuria and Urology.
He most often published in these fields:
- Internal medicine (63.86%)
- Kidney disease (25.09%)
- Endocrinology (21.96%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (63.86%)
- Kidney disease (25.09%)
- Empagliflozin (10.16%)
In recent papers he was focusing on the following fields of study:
Christoph Wanner focuses on Internal medicine, Kidney disease, Empagliflozin, Diabetes mellitus and Type 2 diabetes.
His research integrates issues of Placebo and Cardiology in his study of Internal medicine.
His Kidney disease study integrates concerns from other disciplines, such as Dialysis, Kidney, Clinical trial and Intensive care medicine.
His study looks at the intersection of Empagliflozin and topics like Hazard ratio with Proportional hazards model.
Within one scientific family, Christoph Wanner focuses on topics pertaining to MEDLINE under Diabetes mellitus, and may sometimes address concerns connected to Enzyme replacement therapy.
The Type 2 diabetes study combines topics in areas such as Adverse effect and Disease.
Between 2018 and 2021, his most popular works were:
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (219 citations)
- Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference (190 citations)
- Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA (86 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Enzyme
His main research concerns Internal medicine, Kidney disease, Empagliflozin, Renal function and Heart failure.
Christoph Wanner has included themes like Cardiology and Diabetes mellitus, Nephropathy, Type 2 diabetes, Type 2 Diabetes Mellitus in his Internal medicine study.
His work carried out in the field of Kidney disease brings together such families of science as Dialysis, Clinical trial, Surrogate endpoint and Intensive care medicine.
His Dialysis research is multidisciplinary, incorporating perspectives in Kidney, Confidence interval and Hemodialysis.
Christoph Wanner has researched Renal function in several fields, including Interquartile range, Urology, Clinical endpoint, Hazard ratio and Creatinine.
In his study, Fabry disease is strongly linked to Gastroenterology, which falls under the umbrella field of Creatinine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
